Susquehanna International Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,747
| Closed | -$126K | – | 6880 |
|
|
2025
Q1 | $126K | Buy |
11,747
+2,540
| +28% | +$27.3K | ﹤0.01% | 5761 |
|
|
2024
Q4 | $118K | Buy |
9,207
+3,241
| +54% | +$41.5K | ﹤0.01% | 5615 |
|
|
2024
Q3 | $165K | Buy |
+5,966
| New | +$165K | ﹤0.01% | 4914 |
|
|
2024
Q2 | – | Sell |
-14,129
| Closed | -$630K | – | 6210 |
|
|
2024
Q1 | $630K | Sell |
14,129
-9,840
| -41% | -$439K | ﹤0.01% | 3228 |
|
|
2023
Q4 | $930K | Buy |
23,969
+14,125
| +143% | +$548K | ﹤0.01% | 2969 |
|
|
2023
Q3 | $289K | Buy |
9,844
+189
| +2% | +$5.56K | ﹤0.01% | 4078 |
|
|
2023
Q2 | $614K | Sell |
9,655
-1,341
| -12% | -$85.3K | ﹤0.01% | 3353 |
|
|
2023
Q1 | $519K | Buy |
10,996
+8,230
| +298% | +$388K | ﹤0.01% | 3764 |
|
|
2022
Q4 | $192K | Sell |
2,766
-3,295
| -54% | -$229K | ﹤0.01% | 4522 |
|
|
2022
Q3 | $889K | Buy |
+6,061
| New | +$889K | ﹤0.01% | 2698 |
|
|
2022
Q2 | – | Sell |
-2,213
| Closed | -$223K | – | 6324 |
|
|
2022
Q1 | $223K | Buy |
2,213
+1,698
| +330% | +$171K | ﹤0.01% | 4690 |
|
|
2021
Q4 | $80K | Sell |
515
-1,086
| -68% | -$169K | ﹤0.01% | 5353 |
|
|
2021
Q3 | $474K | Buy |
+1,601
| New | +$474K | ﹤0.01% | 3771 |
|